For the validation purposes, we have used the previously described9 shRNA-encoding vectors to knockdown either PRDX1 or PRDX2 in another model cell line for oestrogen receptor positive breast cancer, ZR-75-1 (Fig. 3a). This evidence concerns the gene PRDX2 and breast carcinoma.